A report released on Tuesday May 4,2010 by the Food and Drug Administration slammed conditions at the factory that produced the children's Tylenol, Motrin and other drugs that were recalled over the weekend.

A major recall of children’s medications in Canada, the United States and several other countries is raising concerns over manufacturing processes used by the company. The report  also highlights significant differences in how the recall is being handled by authorities in the United States and Canada. Further, the agency's reports said the plant's employees were  not given sufficient training in current good manufacturing practices and written procedures required by current good manufacturing practice regulations.

 
McNeil Consumer Healthcare issued a recall over the weekend of more than forty types of infants’ and children’s over-the-counter liquid medication sold in more than ten  countries. The Canadian branch of the company posted a recall alert marking it “urgent” on its website telling consumers to discontinue the  use of eleven children’s and infants’ products. There are Motrin, Zyrtec, Tylenol and Benadryl brand medication for infants and small children, in the form of liquid substances. 
 

Federal health regulators say Johnson & Johnson managers failed to test for contamination of more than 40 varieties of children's cold medicines recalled over the weekend . FDA inspectors said the company did not have laboratory facilities to test drug ingredients and failed to follow up on customer complaints.
 
McNeil Healthcare had issued the Children's medication recall 2010 or the Tylenol, claiming that some medication had more of the active ingredient or tiny particles.